Comparison of Mometasone Furoate Dry Powder Inhaler and Fluticasone Propionate Dry Powder Inhaler in Patients with Moderate to Severe Persistent Asthma Requiring High-Dose Inhaled Corticosteroid Therapy: Findings from a Noninferiority Trial

By Harnest Ulf   Price David   Howes Tim   Sussman Gordon  

Journal of Asthma, Vol. 45, Iss. 3, 2008-04 ,pp. : 215-220

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and Safety of Fluticasone Propionate/Salmeterol HFA 134A MDI in Patients with Mild‐to‐Moderate Persistent Asthma

By Pearlman David   Peden David   Condemi John   Weinstein Steven   White Martha   Baitinger Leslie   Scott Catherine   Ho Shu   House Karen   Dorinsky Paul  

Journal of Asthma, Vol. 41, Iss. 8, 2004-01 ,pp. : 797-806

Informa Healthcare

Access to resources Recommend Favorite

Combination Therapy with Single Inhaler Budesonide/Formoterol Compared with High Dose of Fluticasone Propionate Alone in Patients with Moderate Persistent Asthma

By Bateman E.D.  

American Journal of Respiratory Medicine, Vol. 2, Iss. 3, 2003-01 ,pp. : 275-281

Adis International

Access to resources Recommend Favorite

Effects of Low-Dose Fluticasone Propionate/Salmeterol Combination Therapy on Exhaled Nitric Oxide and Nitrite/Nitrate in Breath Condensates from Patients with Mild Persistent Asthma

By Pasha M. Asghar   Smith Thomas C.   Feustel Paul J.   Jourd’heuil David  

Journal of Asthma, Vol. 50, Iss. 1, 2013-02 ,pp. : 64-70

Informa Healthcare

Access to resources Recommend Favorite

Impact of Inhaled Salmeterol/Fluticasone Propionate Combination Product versus Budesonide on the Health-Related Quality of Life of Patients with Asthma

By Juniper E.F.  

American Journal of Respiratory Medicine, Vol. 1, Iss. 6, 2002-01 ,pp. : 435-440

Adis International

Access to resources Recommend Favorite